Edition:
United States

Vascular Biogenics Ltd (VBLT.A)

VBLT.A on American Stock Exchange

1.33USD
29 Apr 2019
Change (% chg)

-- (--)
Prev Close
$1.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
239
52-wk High
$3.00
52-wk Low
$0.78

About

Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Company's program is based on its Vascular Targeting System (VTS) platform technology, which utilizes genetically targeted therapy to destroy newly... (more)

Overall

Beta: -0.26
Market Cap(Mil.): $47.72
Shares Outstanding(Mil.): 35.88
Dividend: --
Yield (%): --

Financials

  VBLT.A Industry Sector
P/E (TTM): -- 95.23 35.62
EPS (TTM): -0.64 -- --
ROI: -35.88 7.52 11.69
ROE: -37.54 8.09 16.40

Earnings vs. Estimates